Research programme: CNS disorders - Esteve/4SCAlternative Names: CNS disorders research programme
Latest Information Update: 26 Apr 2006
At a glance
- Originator 4SC; Esteve
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported CNS disorders
Most Recent Events
- 26 Apr 2006 No development reported - Preclinical for CNS disorders in Germany (unspecified route)
- 15 Jul 2003 Preclinical trials in CNS disorders in Germany (unspecified route)